It's an exciting time for the biomedical industry. With the rapid integration of technology, AI and machine learning, developments in genomics, biomarkers and data analysis, and increased demand for sustainable health solutions, the opportunities to make an impact feel limitless. Those businesses that thrive will be the ones who can adapt, navigate the rules and regulations and set the right business strategy from the get go. We can help.
For the last two decades, we’ve played a pivotal role in the life sciences and technology sectors supporting the legal needs of companies driving progress to enhance the quality of life of millions of people around the world.
We have clients in all sectors including medical devices, natural health products (NHP), cosmetics, cannabis, veterinary and human tissues and advise in all key areas from artificial intelligence, diagnostics and therapeutics to genetics and precision medicine.
Whether you’re a biotech start-up or a large pharmaceutical we have the experience to support you with whatever challenge you might be facing.
Protecting your most important asset
From concept to market, we help structure IP strategy to protect, maximize and enforce your rights. Our IP professionals across Canada act as one multidisciplinary team providing seamless support with the varying federal and provincial rules and regulations. Many of our lawyers have advanced PhD and Master degrees in STEM fields such as pharmaceutical sciences, endocrinology and genetics, immunology, molecular biology, physics and bioengineering. And should you need help enforcing your rights, our patent and IP litigation team our team is standing out for its numerous important victories.
Support from startup to scale-up
Building a biomedical company means navigating complex regulatory frameworks, protecting critical IP and raising capital in a competitive landscape, all while trying to get your product to market. We get it.
Our Emerging Technology & Venture Capital team has been supporting founders for over 30 years, making us the first and longest-running emerging tech practice at a Canadian law firm.
We offer a national startup programme designed for early-stage biomedical technology companies, covering corporate structuring, seed and venture financings, IP strategy and commercial agreements as you grow. As you scale, our team stays with you through growth-stage rounds, strategic partnerships and, when the time comes, your exit.
We also connect you to the broader ecosystem: SR&ED programme consultants, accounting firms, Schedule 1 banks and some of North America's most prominent incubators, accelerators, universities and public/private research programmes.
Ranked #1 Canadian-based firm for VC deal volume (LSEG, PitchBook 2025)
Mergers & Acquisitions
The trajectory of many venture capital funded technology companies is a successful M&A. We advise buyers, sellers, founders, key shareholders and special committees through this process. We have experience with large and complex cross-border transactions and with varied deal structures, including equity rollovers, exchangeable shares, and hybrid asset/share sales.
Regulatory affairs in life sciences
Our unique skills will be your advantage. Our team is comprised of professionals with advanced scientific degrees and in-house experience at international drug and medical device companies.
We advise on the regulatory aspects of each product development stage from clinical development through to approval and commercialization. We have expertise in clinical trials, market authorization, pricing and reimbursement, post-market vigilance, advertising and promotion, product claims and labeling, quality management and ethical industry standards. We also negotiate and draft related commercial agreements, and advise on how regulatory considerations should be factored into investment, funding or other opportunities.
